Moreover, a pioneer study observed the high levels of interleukin-6 (IL-6), IL-8, IL-10 and tumor necrosis factor-α (TNF-α) in HD patients, all of which were associated with disease progression (Silvestroni et al., 2009). This evidence concerns the gene IL6 and Huntington disease.